The results showed a significant correlation between CHST11 and certain tumor immunostimulators (CD28, IL2RA, and TNFSF13B), tumor immunoinhibitors (CD96 and LGALS9), and MHC proteins (HLA-DRA and HLA-DMB) (Tables S4–S7). Here, HLA-DMB is linked to neoplasm.